LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

Search

WaVe Life Sciences Ltd

Closed

7 1.89

Overview

Share price change

24h

Current

Min

6.75

Max

7.05

Key metrics

By Trading Economics

Income

-76M

-47M

Sales

-75M

9.2M

EPS

-0.29

Profit margin

-510.932

Employees

287

EBITDA

-73M

-48M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+151.82% upside

Dividends

By Dow Jones

Next Earnings

7 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-36M

1B

Previous open

5.11

Previous close

7

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

WaVe Life Sciences Ltd Chart

Past performance is not a reliable indicator of future results.

Related News

11 Oct 2024, 15:56 UTC

Acquisitions, Mergers, Takeovers

GSK Bought More Shares of Biotech Wave Life Sciences -- Barrons.com

Peer Comparison

Price change

WaVe Life Sciences Ltd Forecast

Price Target

By TipRanks

151.82% upside

12 Months Forecast

Average 17.25 USD  151.82%

High 24 USD

Low 9 USD

Based on 9 Wall Street analysts offering 12 month price targets forWaVe Life Sciences Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

6.35 / 6.555Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$